This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Modi, Paytm & Midnight Demonetization: June Market Strategy
by John Blank
Let's discuss dumb policy execution -- well outside of the 2017 U.S. media focus on all things Trump.
Zacks.com featured highlights: Lear, International Consolidated Airlines Group, Monsanto, Applied Materials and Sandvik
by Zacks Equity Research
Zacks.com featured highlights: Lear, International Consolidated Airlines Group, Monsanto, Applied Materials and Sandvik
Modi, Paytm & Midnight Demonetization: June Market Strategy
by John Blank
Let's discuss dumb policy execution -- well outside of the 2017 U.S. media focus on all things Trump.
Zacks.com featured highlights: Lear, International Consolidated Airlines Group, Monsanto, Ternium and Sandvik AB
by Zacks Equity Research
Zacks.com featured highlights: Lear, International Consolidated Airlines Group, Monsanto, Ternium and Sandvik AB
Zacks.com featured highlights: Lear, BT Group, Monsanto, Ternium S.A. and Credicorp
by Zacks Equity Research
Zacks.com featured highlights: Lear, BT Group, Monsanto, Ternium S.A. and Credicorp
Zacks.com featured highlights: Conagra Brands, Broadcom, Monsanto, Ternium and Credicorp
by Zacks Equity Research
Zacks.com featured highlights: Conagra Brands, Broadcom, Monsanto, Ternium and Credicorp
Monsanto (MON) Beats on Q2 Earnings & Revenues
by Zacks Equity Research
Monsanto Company (MON) reported better-than-expected second-quarter fiscal 2017 results.
Earnings Season in Focus
by Zacks Equity Research
Earnings Season in Focus
Plenty to Look Forward To
by Mark Vickery
We are anticipating another strong quarter of growth as Q1 earnings season starts in the next couple weeks.
Acuity Brands, Monsanto, Constellation Brands, Walgreens-Boots and CarMax are part of Zacks Earnings Preview
by Zacks Equity Research
Acuity Brands, Monsanto, Constellation Brands, Walgreens-Boots and CarMax are part of Zacks Earnings Preview
Chemical Industry Back on Track: Stocks Worth a Look
by Zacks Equity Research
Strength in the automotive sector and a rebound in non-residential construction and housing markets have helped pull the industry out of its funk.
The Zacks Analyst Blog Highlights: Dow Chemical, E. I. du Pont de Nemours, Syngenta AG and Monsanto
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Dow Chemical, E. I. du Pont de Nemours, Syngenta AG and Monsanto
Monsanto & 3 Other Basic Material Picks to Boost Gains
by Zacks Equity Research
The broader Materials Select sector SPDR (XLB) has gained 5.31%, since Jan 1. The upside was driven by stellar performances of major materials stock like Monsanto Company (MON).
Vale S.A. (VALE) Looks Bullish on Robust Growth Drivers
by Zacks Equity Research
We issued an updated research report on Vale S.A. (VALE) on Mar 16.
Top Research Reports for March 1, 2017
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Canadian National (CNI) and BP (BP).
Cosan (CZZ) Incurs Loss in Q4 on Weak Sales and Margins
by Zacks Equity Research
Cosan Limited (CZZ) reported weak results for fourth-quarter 2016. Net loss totaled R$38.1 million (US$11.5 million) as compared with net earnings of R$356.7 million (US$92.6 million) reported in the year-ago quarter.
Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line
by Zacks Equity Research
Bayer AG's (BAYRY) fourth-quarter 2016 core earnings increased 10.2% year over year to ???1.19 per share (approximately $1.28). Reported earnings missed the Zacks Consensus Estimate of $1.37.
Top Ranked Momentum Stocks to Buy for January 26th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 26th:
Monsanto Ties Up with NRGene to Boost Technology Platform
by Zacks Equity Research
Monsanto Company (MON) and NRGene recently entered into a non-exclusive, multi-year global licensing agreement.
Monsanto (MON) Upgraded to Buy on Solid Growth Drivers
by Zacks Equity Research
On Jan 10, 2017, Zacks Investment Research upgraded Monsanto Company (MON) to a Zacks Rank #2 (Buy) from a Zacks Rank #3 (Hold).
Stock Research Reports for Wal-Mart, Exxon & Qualcomm
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Wal-Mart (WMT), Exxon Mobil (XOM) and QUALCOMM (QCOM).
Vale's (VALE) Stock Looks Promising on Growth Initiatives
by Zacks Equity Research
We issued an updated research report on Vale S.A. (VALE) on Jan 6, 2017.
Monsanto (MON) Tops Q1 Earnings, Gives FY 2017 Guidance
by Zacks Equity Research
Monsanto Company (MON) reported better-than-expected first-quarter fiscal 2017 (ended Nov 30, 2016) results.
Monsanto (MON) Beats Q1 Earnings, Revenues Up Y/Y
by Zacks Equity Research
Monsanto Company (MON) reported first-quarter fiscal 2017 adjusted earnings of 21 cents, on an ongoing basis.
Good Reasons to Bet on Chemical Stocks
by Zacks Equity Research
The shale gas revolution in the U.S. has been a huge driving force behind chemical investment on plants and equipment.